Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1973 1
1974 5
1975 1
1976 4
1977 6
1978 3
1979 4
1980 5
1981 5
1982 2
1984 7
1985 8
1986 2
1987 2
1988 5
1989 10
1990 10
1991 9
1992 10
1993 11
1994 11
1995 1
1996 5
1997 6
1998 15
1999 10
2000 15
2001 22
2002 18
2003 19
2004 17
2005 18
2006 23
2007 15
2008 26
2009 19
2010 17
2011 22
2012 22
2013 27
2014 26
2015 24
2016 23
2017 33
2018 30
2019 32
2020 36
2021 25
2022 24
2023 16
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

641 results

Results by year

Filters applied: . Clear all
Page 1
Lobular Carcinoma In Situ.
Wen HY, Brogi E. Wen HY, et al. Surg Pathol Clin. 2018 Mar;11(1):123-145. doi: 10.1016/j.path.2017.09.009. Epub 2017 Dec 8. Surg Pathol Clin. 2018. PMID: 29413653 Free PMC article. Review.
Lobular carcinoma in situ (LCIS) is a risk factor and a nonobligate precursor of breast carcinoma. ...
Lobular carcinoma in situ (LCIS) is a risk factor and a nonobligate precursor of breast carcinoma. ...
Management of High-Risk Breast Lesions.
Bahl M. Bahl M. Radiol Clin North Am. 2021 Jan;59(1):29-40. doi: 10.1016/j.rcl.2020.08.005. Radiol Clin North Am. 2021. PMID: 33222998 Review.
Contrast-enhanced MRI for breast cancer screening.
Mann RM, Kuhl CK, Moy L. Mann RM, et al. J Magn Reson Imaging. 2019 Aug;50(2):377-390. doi: 10.1002/jmri.26654. Epub 2019 Jan 18. J Magn Reson Imaging. 2019. PMID: 30659696 Free PMC article. Review.
Particularly in women with a personal history of breast cancer, the gain seems to be high, but also in women with a biopsy history of lobular carcinoma in situ and even women at average risk, similar results are reported. ...
Particularly in women with a personal history of breast cancer, the gain seems to be high, but also in women with a biopsy history of lob …
Lobular Neoplasia.
Lunt L, Coogan A, Perez CB. Lunt L, et al. Surg Clin North Am. 2022 Dec;102(6):947-963. doi: 10.1016/j.suc.2022.07.001. Surg Clin North Am. 2022. PMID: 36335930 Review.
Lobular neoplasia (LN) is a term that describes atypical epithelial lesions originating in the terminal duct-lobular unit (TDLU) of the breast, including atypical lobular hyperplasia (ALH) and lobular carcinoma in situ (LCIS). LN is both a risk factor …
Lobular neoplasia (LN) is a term that describes atypical epithelial lesions originating in the terminal duct-lobular unit (TDLU) of the brea …
Lobular neoplasia.
King TA, Reis-Filho JS. King TA, et al. Surg Oncol Clin N Am. 2014 Jul;23(3):487-503. doi: 10.1016/j.soc.2014.03.002. Epub 2014 Apr 16. Surg Oncol Clin N Am. 2014. PMID: 24882347 Review.
Lobular carcinoma in situ: diagnostic criteria and molecular correlates.
Sokolova A, Lakhani SR. Sokolova A, et al. Mod Pathol. 2021 Jan;34(Suppl 1):8-14. doi: 10.1038/s41379-020-00689-3. Epub 2020 Oct 6. Mod Pathol. 2021. PMID: 33024303 Free article. Review.
Lobular neoplasia (LN) is an atypical proliferation of small, dyscohesive epithelial cells within the terminal duct lobular unit (TDLU), with or without pagetoid extension and encompasses both lobular carcinoma in situ (LCIS) and atypical lobular hyper …
Lobular neoplasia (LN) is an atypical proliferation of small, dyscohesive epithelial cells within the terminal duct lobular unit (TDLU), wit …
Update on Lobular Neoplasia.
Heller SL, Gao Y. Heller SL, et al. Radiographics. 2023 Oct;43(10):e220188. doi: 10.1148/rg.220188. Radiographics. 2023. PMID: 37676825 Review.
Lobular neoplasia (LN) is a histopathologic entity that encompasses both lobular carcinoma in situ (LCIS) and atypical lobular hyperplasia (ALH). ...
Lobular neoplasia (LN) is a histopathologic entity that encompasses both lobular carcinoma in situ (LCIS) and at …
Lobular Carcinoma In Situ during Preoperative Biopsy and the Rate of Upgrade.
Lee J, Ku GY, Lee H, Park HS, Ku JS, Kim JY, Park S, Park BW. Lee J, et al. Cancer Res Treat. 2022 Oct;54(4):1074-1080. doi: 10.4143/crt.2021.864. Epub 2021 Dec 21. Cancer Res Treat. 2022. PMID: 34942684 Free PMC article.
PURPOSE: There is a potential risk that lobular carcinoma in situ (LCIS) on preoperative biopsy might be diagnosed as ductal carcinoma in situ (DCIS) or invasive carcinoma in the final pathology. ...
PURPOSE: There is a potential risk that lobular carcinoma in situ (LCIS) on preoperative biopsy might be diagnos …
How Do We Approach Benign Proliferative Lesions?
Nakhlis F. Nakhlis F. Curr Oncol Rep. 2018 Mar 23;20(4):34. doi: 10.1007/s11912-018-0682-1. Curr Oncol Rep. 2018. PMID: 29572753 Review.
PURPOSE OF REVIEW: The aim of this review is to summarize recently published literature addressing atypical ductal hyperplasia (ADH), lobular neoplasia (atypical lobular hyperplasia [ALH] and classic lobular carcinoma in situ [C-LCIS]), non-classic …
PURPOSE OF REVIEW: The aim of this review is to summarize recently published literature addressing atypical ductal hyperplasia (ADH), lobula …
Premalignant Disorders of the Breast in Pregnancy and Lactation.
Omranipour R, Alipour S, Ensani F, Nakhlis F. Omranipour R, et al. Adv Exp Med Biol. 2020;1252:63-72. doi: 10.1007/978-3-030-41596-9_8. Adv Exp Med Biol. 2020. PMID: 32816263 Review.
Papillomas, atypical hyperplasias, and lobular carcinoma in situ of the breast are not malignant tumors, but present serious management challenges when they are diagnosed in a breast biopsy . ...
Papillomas, atypical hyperplasias, and lobular carcinoma in situ of the breast are not malignant tumors, but pre …
641 results